Dna Brands Stock Net Income
| DNAX Stock | USD 0.0001 0.00 0.00% |
DNA Brands technical analysis allows you to utilize past data patterns in order to determine a pattern that computes the direction of the firm's future prices.
DNA Brands' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing DNA Brands' valuation are provided below:DNA Brands does not right now have any fundamental measures for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. DNA |
DNA Brands 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to DNA Brands' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of DNA Brands.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in DNA Brands on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding DNA Brands or generate 0.0% return on investment in DNA Brands over 90 days. DNA Brands is related to or competes with Dnd Technologies. It offers products in various flavors, such as cellular citrus zero sugar, cellular citrus, cryo berry, and molecular me... More
DNA Brands Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure DNA Brands' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess DNA Brands upside and downside potential and time the market with a certain degree of confidence.
DNA Brands Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for DNA Brands' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as DNA Brands' standard deviation. In reality, there are many statistical measures that can use DNA Brands historical prices to predict the future DNA Brands' volatility.DNA Brands Backtested Returns
DNA Brands retains Efficiency (Sharpe Ratio) of 0.16, which denotes the company had a 0.16 % return per unit of risk over the last 3 months. We were able to analyze three different technical indicators, which can help you to evaluate if expected returns of 29.51% are justified by taking the suggested risk. The firm owns a Beta (Systematic Risk) of 0.0, which means not very significant fluctuations relative to the market. the returns on MARKET and DNA Brands are completely uncorrelated.
Auto-correlation | -0.03 |
Very weak reverse predictability
DNA Brands has very weak reverse predictability. Overlapping area represents the amount of predictability between DNA Brands time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of DNA Brands price movement. The serial correlation of -0.03 indicates that only 3.0% of current DNA Brands price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.03 | |
| Spearman Rank Test | 0.9 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, DNA Brands reported net income of (1.25 Million). This is 100.11% lower than that of the Beverages sector and significantly lower than that of the Consumer Staples industry. The net income for all United States stocks is 100.22% higher than that of the company.
DNA Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses DNA Brands' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of DNA Brands could also be used in its relative valuation, which is a method of valuing DNA Brands by comparing valuation metrics of similar companies.DNA Brands is currently under evaluation in net income category among its peers.
DNA Fundamentals
| Operating Margin | (0.98) % | |||
| Current Valuation | 1.47 M | |||
| Shares Outstanding | 22.07 K | |||
| Price To Earning | 0.20 X | |||
| Price To Sales | 0.11 X | |||
| Revenue | 249.01 K | |||
| Gross Profit | 249.01 K | |||
| EBITDA | (239.66 K) | |||
| Net Income | (1.25 M) | |||
| Cash And Equivalents | 499 | |||
| Total Debt | 2 M | |||
| Current Ratio | 0.01 X | |||
| Book Value Per Share | (0.92) X | |||
| Cash Flow From Operations | (1.1 M) | |||
| Earnings Per Share | 0.02 X | |||
| Beta | 1.14 | |||
| Market Capitalization | 33.98 K | |||
| Total Asset | 327 K | |||
| Retained Earnings | (30.44 M) | |||
| Working Capital | (3.12 M) | |||
| Current Asset | 319 K | |||
| Current Liabilities | 3.43 M |
About DNA Brands Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze DNA Brands's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of DNA Brands using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of DNA Brands based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for DNA Pink Sheet Analysis
When running DNA Brands' price analysis, check to measure DNA Brands' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DNA Brands is operating at the current time. Most of DNA Brands' value examination focuses on studying past and present price action to predict the probability of DNA Brands' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DNA Brands' price. Additionally, you may evaluate how the addition of DNA Brands to your portfolios can decrease your overall portfolio volatility.